Cutting Edge Research

Oklahoma City, Oklahoma 73116-1423

0 studies enrolling now · 9 studies all time

What they study most

Autism Spectrum Disorders, Autistic Disorder, Behavioral Symptoms, Bipolar Disorder, Chronic Pain, Major Depressive Disorder, Osteoarthritis

Studies at this site

• Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD) — Completed
• Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder — Completed
• A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode — Completed
• Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD) — Completed
• Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) — Stopped early
• Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder — Completed
• A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee — Completed
• Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders — Completed
• Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders — Stopped early